Special palliative care unit
MTMH has a dedicated palliative care unit, funded by the Suri Seva Foundation and helmed by specialists with more than 20 years of experience in the field.
MTMH has a dedicated palliative care unit, funded by the Suri Seva Foundation and helmed by specialists with more than 20 years of experience in the field.
The department of Nuclear Medicine has a routine PET CT Scan and a Low-Dose Therapy ward, where 177-Lu PSMA therapy is available for hormone-resistant prostate cancer.
The diagnostic centre at MTMH is equipped with two CT machines (128-slice and 32-slice emergency CT), a 3 Tesla MRI, a 1.5 Tesla MRI, PET-CT, ultrasound, digital mammography, and digital X-ray facilities. CT-guided and ultrasound-guided biopsies, as well as FNAC, are routinely done.
A specialist-helmed multi-disciplinary tumour board has been set up to ensure that all patients get the best treatment plan at MTMH.
Pathology provides immunohistochemistry as an advanced test, besides histopathology, cytology, tumour markers, drug levels like Methotrexate and routine tests. Real-time PCR-based EGFR panel, HRHPV on FFPE, BCR ABL with IS% on Peripheral and bone marrow samples are also carried out.